PMC:7408073 / 63262-63367
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T397 | 64-69 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T133 | 64-69 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 2278 | 0-9 | Chemical | denotes | CaNa2EDTA |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T794 | 64-69 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| T795 | 64-69 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
| T796 | 82-83 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T303 | 0-105 | Sentence | denotes | CaNa2EDTA was approved by FDA in chelation therapy for lowering blood lead levels a long time ago (1953). |